TM

Tilak K. Verma M.D.

Medical Director For Medical Policy at Point32Health

Tilak K. Verma MD MBA has extensive experience in the healthcare industry. Tilak K. has served as the Medical Director for Medical Policy at Point32Health Tufts Health Plan & Harvard Pilgrim Health Plan since October 2018. Prior to that, they worked at Tufts Health Plan as a Sleep Program Management/Subject Matter Expert, Innovation Fellow, and Senior Medical Director from 2016 to 2018. Tilak K. also held roles at Care Transformation Collaborative of Rhode Island and State Innovation Model Rhode Island from 2016 to 2018. Before that, Dr. Verma was a Lung and Sleep Specialist at Lung Diseases & Respiratory Care, Inc., a Regional Medical Director at UnitedHealthcare, and a Board Certified Specialist in Internal Medicine, Pulmonary, Critical Care & Sleep Medicine at Sleep HealthCenters. Tilak K. has also served as the President of the Rhode Island Medical Society and has held leadership positions at Landmark Medical Center, RI.

Tilak K. Verma MD MBA received their Bachelor of Medicine and Bachelor of Surgery (M.B.B.S) from Delhi University. Tilak K. later pursued their education at Temple University - Lewis Katz School of Medicine, specializing in Pulmonary Medicine. Tilak K. then attended Harvard Medical School - Massachusetts General Hospital, where they completed a program in Respiratory Intensive Care.

In addition to their medical education, Tilak Verma also holds a Master of Business Administration (MBA) degree from Bryant University, with a focus on Health/Health Care Administration/Management.

Tilak Verma has obtained several certifications, including Critical Care Medicine, Internal Medicine, Pulmonary Diseases, and Sleep Medicine, from institutions such as the American Board of Internal Medicine and the AMERICAN BOARD OF SLEEP MEDICINE. The specific months and years of obtaining these certifications are not provided.

Links

Previous companies

UnitedHealth Group logo

Timeline

  • Medical Director For Medical Policy

    October, 2018 - present